Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Lavender Bina Cendikia Tbk. (BMBL) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance

Lavender Bina Cendikia Tbk.Trade
UBC Medical Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Lavender Bina Cendikia Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Lavender Bina Cendikia Tbk. trades at Rp30 (market cap 30.9B, 2.96M 24h volume), while UBC Medical Indonesia Tbk. trades at Rp146 (market cap 584.6B, 817.3K 24h volume). The key difference: UBC Medical Indonesia Tbk. is far larger — about 18.9× Lavender Bina Cendikia Tbk.'s market cap, and Lavender Bina Cendikia Tbk. is more actively traded (2.96M versus 817.3K). Which is the better fit depends on your goals.

BMBLLABS
Market Cap
30.9B584.6B
Volume
2.96M817.3K
Lot
29.64K8.17K
Turnover
88.75M120.01M
Average Price
29.94146.84
Value
88.75M120.01M
Indicative Equilibrium Price
30146
Indicative Equilibrium Volume
159

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

BMBL
View details
LABS
View details

About Lavender Bina Cendikia Tbk.

PT Lavender Bina Cendikia Tbk ("Company") was established on November 27, 2013 based on theNotarial deed of Suparman Hasyim, S.H., No. 35. The Company started its commercial operations in2013. The ultimate beneficial owner of the Company is Galih Pandekar.

Read more on BMBL

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS